Kestra Medical Technologies, Ltd.
KMTS
$24.83
-$0.38-1.51%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.06% | -34.72% | -20.92% | -- | -- |
| Total Depreciation and Amortization | -26.86% | -34.23% | -31.07% | -- | -- |
| Total Amortization of Deferred Charges | 17.33% | 137.24% | 129.51% | -- | -- |
| Total Other Non-Cash Items | 658.64% | 582.50% | 486.92% | -- | -- |
| Change in Net Operating Assets | -2,201.34% | -609.15% | -290.12% | -- | -- |
| Cash from Operations | -30.77% | -25.26% | -7.48% | -- | -- |
| Capital Expenditure | -33.70% | -39.68% | -90.09% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.06% | 178.72% | 78.95% | -- | -- |
| Cash from Investing | -33.52% | -38.20% | -90.35% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | 37.87% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -148.03% | -155.60% | 375.98% | -- | -- |
| Cash from Financing | 52.12% | 26.89% | 324.91% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.09% | 25.80% | 3,503.26% | -- | -- |